Walleye Capital’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
Walleye Capital's SGMT Position: Q3 2026 in Review
Walleye Capital opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 307,785 shares worth $3.04M. The stake represents ﹤0.01% of the portfolio and ranks #2405 among its holdings.
151 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- Walleye Capital held 307,785 shares of Sagimet Biosciences worth $3.04M as of Q3 2026.
- Sagimet Biosciences was a new Walleye Capital position in Q3 2026.
- Sagimet Biosciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2405 holding.
- 151 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.